Search - tctmd.com

Displaying 141 - 160 of 1180

Sort: Relevancy | Date

News Daily News

Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI

L.A. McKeown

January 31, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Michael O'Riordan

January 17, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

Todd Neale

January 14, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Caitlin E. Cox

December 11, 2018

News Daily News

Proposed Legislation Readies Another Arrow at the Medical Device Excise Tax

Yael L. Maxwell

December 11, 2018

News Daily News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

L.A. McKeown

December 07, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

Another Blow to the Medical Device Tax as House Votes to Repeal

Yael L. Maxwell

July 26, 2018

News Daily News

Chew on This: Review Tackles Controversies in Nutrition for CV Health

Lucy Hicks

July 23, 2018

News Daily News

High-Risk Medical Device Approval Process in Europe Inches Towards Transparency

Michael O'Riordan

July 20, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

Advertisement

Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Proposed Legislation Readies Another Arrow at the Medical Device Excise Tax

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Another Blow to the Medical Device Tax as House Votes to Repeal

Chew on This: Review Tackles Controversies in Nutrition for CV Health

High-Risk Medical Device Approval Process in Europe Inches Towards Transparency

Discharge Against Medical Advice After PCI Rare but Deadly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content